Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1B1 | P15121 | 1/20 | 0.36 |
| ▸ | ABCC9 | O60706 | 5/20 | 0.35 |
| ▸ | KCNJ11 | Q14654 | 5/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | ABCC8 | Q09428 | 2/20 | 0.33 |
| ▸ | KCNJ8 | Q15842 | 2/20 | 0.33 |
| ▸ | KDM1A | O60341 | 2/20 | 0.31 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23362436 | 1.00 | AKR1B1 (0.36) | AKR1B1ABCC9KCNJ11BACE1ABCC8 | |
| SCHEMBL23362946 | 0.80 | GRIN2D (0.38) | TSHR | |
| SCHEMBL29640640 | 0.80 | GRIN2D (0.38) | TSHR | |
| SCHEMBL20338949 | 0.78 | CYP1A1 (0.36) | TSHR | |
| SCHEMBL15589554 | 0.75 | BACE1 (0.39) | AKR1B1ABCC9KCNJ11BACE1ABCC8 | |
| SCHEMBL21544077 | 0.75 | JAK2 (0.42) | — | |
| SCHEMBL29913808 | 0.75 | JAK2 (0.42) | — | |
| SCHEMBL29920352 | 0.74 | MAOB (0.41) | — | |
| SCHEMBL29920575 | 0.74 | MAOB (0.41) | — | |
| SCHEMBL3183702 | 0.74 | FABP6 (0.46) | AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114641477-A | Novel compound having inhibitory activity against glucose ceramide synthase or pharmaceutically acceptable salt thereof, method for preparing same, and pharmaceutical composition comprising same | 柳韩洋行 | 2022-06-17 | — | — | CN | disclosed |